Determination of dabigatran and rivaroxaban by ultra-performance liquid chromatography-tandem mass spectrometry and coagulation assays after major orthopaedic surgery
Authors:
- 1 March 2016
- journal article
- clinical trial
- Published by Elsevier in Thrombosis Research
- Vol. 139, 128-134
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Determination of dabigatran, rivaroxaban and apixaban by ultra‐performance liquid chromatography – tandem mass spectrometry (UPLC‐MS/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulantsJournal of Thrombosis and Haemostasis, 2014
- On the monitoring of dabigatran treatment in “real life” patients with atrial fibrillationThrombosis Research, 2014
- The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation PatientsJACC, 2014
- A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustmentThrombosis and Haemostasis, 2014
- Performance of coagulation tests in patients on therapeutic doses of dabigatran: a cross‐sectional pharmacodynamic study based on peak and trough plasma levelsJournal of Thrombosis and Haemostasis, 2013
- Impact of apixaban on routine and specific coagulation assays: a practical laboratory guideThrombosis and Haemostasis, 2013
- The effect of dabigatran on the activated partial thromboplastin time and thrombin time as determined by the Hemoclot thrombin inhibitor assay in patient plasma samplesThrombosis and Haemostasis, 2013
- A Novel Prothrombin Time Assay for Assessing the Anticoagulant Activity of Oral Factor Xa InhibitorsClinical and Applied Thrombosis/Hemostasis, 2012
- Laboratory assessment of new anticoagulantsClinical Chemistry and Laboratory Medicine (CCLM), 2011
- Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: a population model analysisBritish Journal of Clinical Pharmacology, 2006